Review
Published on 12 Feb 2024
Acute kidney injury: exploring endoplasmic reticulum stress-mediated cell death
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1308733
- 2,760 views
- 3 citations
Type at least 3 characters
589 articles
Articles
Brief Research Report
Published on 05 Feb 2024
Mitophagy regulates mitochondrial number following pharmacological induction of mitochondrial biogenesis in renal proximal tubule cells
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1344075
- 1,763 views
- 3 citations
Brief Research Report
Published on 01 Feb 2024
Determination of glomerular filtration rate “en passant” after high doses of iohexol for computed tomography in intensive care medicine—a proof of concept
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1346343
- 1,776 views
Original Research
Published on 23 Jan 2024
Unravelling the role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1279330
- 1,595 views
- 1 citation
Mini Review
Published on 22 Jan 2024
Ceftazidime-avibactam induced renal disorders: past and present
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1329307
- 2,642 views
- 2 citations
Review
Published on 19 Jan 2024
Urinary biomarkers associated with podocyte injury in lupus nephritis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1324540
- 2,815 views
- 2 citations
Original Research
Published on 19 Jan 2024
Kidney derived apolipoprotein M and its role in acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1328259
- 1,843 views
Review
Published on 16 Jan 2024
The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1335094
- 4,384 views
- 7 citations
Editorial
Published on 15 Jan 2024
Editorial: Transporters: a hitchhiker’s guide to physiology, toxicology, and pharmacology—TransportDays 2022
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1365106
- 878 views
Systematic Review
Published on 11 Jan 2024
Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1237583
- 2,028 views
- 1 citation
Original Research
Published on 09 Jan 2024
Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1319744
- 1,659 views
Editorial
Published on 09 Jan 2024
Editorial: Global excellence in renal pharmacology 2022: Central and South America
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1362010
- 778 views
Original Research
Published on 08 Jan 2024
Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1309930
- 1,630 views
Review
Published on 08 Jan 2024
Pharmacological functions of salidroside in renal diseases: facts and perspectives
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1309598
- 12,196 views
- 7 citations
Original Research
Published on 03 Jan 2024
Klotho-derived peptide KP1 ameliorates SARS-CoV-2-associated acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1333389
- 2,545 views
- 4 citations
Original Research
Published on 22 Dec 2023
Efficacy and safety of rituximab in elderly patients with membranous nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1323334
- 2,067 views